Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz



FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
About the Company : Luna Greentech is an innovative company, recognized for the development of technological and sustainable innovations in the production of natural ingredients for cosmetics. We are ...

About the Company : PK Components is a Polish distributor of raw materials for the production of dietary supplements and for the food industry. Our hallmark is a stable market position, customer trust...

About the Company : Specializing in the health industry, LonierHerb Ltd specializes in plant extracts and offers a comprehensive service chain that encompasses micro-encapsulation, natural colorants, ...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Details:
Lactoperoxidase is a Enzyme drug candidate, which is currently being evaluated in clinical studies for the treatment of Xerostomia.
Lead Product(s): Lactoperoxidase,Glucose Oxidase,Lactoferrin,Lysozyme,Calcium,Ribitol,Aloe vera,Natural Peppermint
Therapeutic Area: Dental and Oral Health Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Enzyme
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable May 22, 2025

Lead Product(s) : Lactoperoxidase,Glucose Oxidase,Lactoferrin,Lysozyme,Calcium,Ribitol,Aloe vera,Natural Peppermint
Therapeutic Area : Dental and Oral Health
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Oral7 Mouth Spray Effect On Xerostomia and Oral Health In Older Adults
Details : Lactoperoxidase is a Enzyme drug candidate, which is currently being evaluated in clinical studies for the treatment of Xerostomia.
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Inapplicable
May 22, 2025

Details:
Soy Protein Isolate is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Osteoarthritis.
Lead Product(s): Soy Protein Isolate,Soybean Peptide,Wheat Protein,Pea Protein,Pea Peptide,Aloe vera
Therapeutic Area: Musculoskeletal Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Undisclosed
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 12, 2024

Lead Product(s) : Soy Protein Isolate,Soybean Peptide,Wheat Protein,Pea Protein,Pea Peptide,Aloe vera
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Soy Protein Isolate is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Osteoarthritis.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
July 12, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
UP360 is a naturally-derived extracts from both the Poria cocos mushroom and rosemary as well as Aloe vera gel powder. The UP360 produces antioxidant, anti-inflammatory, and immunomodulatory effects.
Lead Product(s): Poria Cocos Mushroom Extract,Aloe vera,Rosemary Extract
Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Plant Extract/Herbal
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable May 03, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Poria Cocos Mushroom Extract,Aloe vera,Rosemary Extract
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : UP360 is a naturally-derived extracts from both the Poria cocos mushroom and rosemary as well as Aloe vera gel powder. The UP360 produces antioxidant, anti-inflammatory, and immunomodulatory effects.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
May 03, 2023

Details:
Aloe Vera is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Irritable Bowel Syndrome.
Lead Product(s): Aloe vera,Inapplicable
Therapeutic Area: Gastroenterology Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Undisclosed
Sponsor: Calmino group AB
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 22, 2011

Lead Product(s) : Aloe vera,Inapplicable
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Calmino group AB
Deal Size : Inapplicable
Deal Type : Inapplicable
Aloe Vera in Irritable Bowel Syndrome
Details : Aloe Vera is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Irritable Bowel Syndrome.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
July 22, 2011

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Market Place
Reply
30 Aug 2022
Reply
12 Aug 2021
Reply
16 Jul 2021
Reply
14 Jul 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
Contact Us!